Luigi Mangione's lawyers have withdrawn their plan to pursue a psychiatric defense in the state murder trial for the shooting death of UnitedHealthcare executive Brian Thompson. Mangione has pleaded not guilty to murder and federal stalking charges.
The decision to drop the psychiatric defense significantly alters the legal strategy for Luigi Mangione, potentially impacting the outcome of his state murder trial and the charges he faces.
Lawyers for Luigi Mangione, the defendant accused of killing UnitedHealthcare Chief Executive Brian Thompson, have reversed their decision to pursue a psychiatric defense in the state murder trial. The reversal came a day after Mangione's attorneys informed Judge Gregory Carro of their intention to argue that their client was suffering from "extreme emotional disturbance at the time of the occurrence." Mangione, 28, has pleaded not guilty in both the federal and state cases related to the fatal shooting of Thompson, 50, in midtown Manhattan on December 4, 2024. The decision to abandon the psychiatric defense was made ahead of a Thursday deadline for Mangione's legal team to provide prosecutors with supporting information for such a claim. Legal expert Richard Schoenstein explained that a successful psychiatric defense would have essentially admitted to killing Thompson but with mitigating circumstances, potentially leading to a manslaughter conviction instead of murder, which carries a shorter prison sentence. This differs from a plea of not guilty by reason of insanity, which typically seeks exoneration and commitment to a psychiatric facility. Mangione appeared in court on Wednesday as the judge discussed the planned psychiatric defense. His next court date is scheduled for August 11, with the state trial set to commence on September 8. He is also facing federal stalking charges, which carry a maximum sentence of life in prison.